Further, in vitro studies revealed that ZHX1 overexpression resulted in a reduction in GBM cell apoptosis via inhibition of apoptotic protein Bax and promotion of anti-apoptotic protein Bcl-2. The gene discussed is BCL2; the disease is glioblastoma.